DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post 
KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
Alphabet Replaces Verizon in Dow Jones Industrial Average 
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence 
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi 
Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan 
FedEx Stock Drops After Weak 2026 Earnings Forecast Despite Strong Q4 Results 
NTSB Investigates Boston Logan Airport Near-Miss Between Delta and American Airlines Jets 
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast 
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates 
Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom 
Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites 
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
Apollo Debt Solutions Limits Redemptions as Withdrawal Requests Surge 
BURLINGTON, Mass., Feb. 19, 2016 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, CFO, will participate in BTIG’s annual Medical Technology, Diagnostics, and Healthcare IT Conference from February 24-26, 2016 in Snowbird, Utah.
For more information or to register, please visit the conference website at www.btig.com.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at http://www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Sandra Millar +1-781-425-1686 [email protected] http://www.lemaitre.com
